Physician profile
Edgar Aleman
NPI 1023072253
$10,543.63
in general payments reported to CMS, 2019-2025
30 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $1,090 · 2021: $1,285 · 2022: $1,172 · 2023: $2,328 · 2024: $1,503 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,358 · Travel and Lodging: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,358.34 |
| Travel and Lodging | $795.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,552.71 | 2019-2025 | Supera, Pressurewire, Xience Skypoint |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,100.73 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $607.09 | 2020-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $587.58 | 2020-2025 | |
| Medtronic Vascular, INC. | $456.97 | 2019-2020 | |
| Novo Nordisk INC | $428.25 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Esperion Therapeutics, INC. | $387.22 | 2020-2024 | Nexletol |
| Boston Scientific Corporation | $311.63 | 2019-2025 | Bodyguardian, Watchman Flx, Resonate El Icd Vr |
| E.R. Squibb & Sons, L.L.C. | $308.51 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $263.80 | 2019-2025 | |
| Amgen INC. | $225.83 | 2019-2025 | Repatha |
| Medtronic, INC. | $223.49 | 2023-2024 | Micra, Corevalve Evolut R |
| Irhythm Technologies, INC. | $178.33 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $167.56 | 2023 | Impella |
| Impulse Dynamics (USA) INC. | $142.02 | 2022-2023 | Optimizer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $135.28 | 2022-2025 | Assure Wcd |
| Heartflow, INC. | $84.09 | 2024-2025 | |
| Baxter Healthcare | $78.95 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Preventice Services, LLC | $45.55 | 2021 | |
| Atricure, INC. | $41.97 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $30.31 | 2019 | |
| Ge Healthcare | $25.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.90 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $23.11 | 2023 | Inpefa |
| Biotronik INC. | $21.05 | 2024 | Biomonitor |
| Philips North America LLC | $20.08 | 2023 | |
| Glaxosmithkline, LLC. | $19.07 | 2025 | Arexvy, Shingrix |
| Cook Medical LLC | $18.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.86 | 2021 | |
| Cardiva Medical, INC. | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Aleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.